- Home
- AVIR vs CDZI Comparison
AVIR vs CDZI Comparison
Compare AVIR & CDZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- CDZI
- Stock Information
- Founded
- AVIR 2012
- CDZI 1983
- Country
- AVIR United States
- CDZI United States
- Employees
- AVIR N/A
- CDZI N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- CDZI Water Supply
- Sector
- AVIR Health Care
- CDZI Utilities
- Exchange
- AVIR Nasdaq
- CDZI Nasdaq
- Market Cap
- AVIR 273.7M
- CDZI 238.2M
- IPO Year
- AVIR 2020
- CDZI N/A
- Fundamental
- Price
- AVIR $2.97
- CDZI $2.95
- Analyst Decision
- AVIR Hold
- CDZI
- Analyst Count
- AVIR 1
- CDZI 0
- Target Price
- AVIR $6.00
- CDZI N/A
- AVG Volume (30 Days)
- AVIR 441.1K
- CDZI 412.0K
- Earning Date
- AVIR 05-12-2025
- CDZI 05-14-2025
- Dividend Yield
- AVIR N/A
- CDZI N/A
- EPS Growth
- AVIR N/A
- CDZI N/A
- EPS
- AVIR N/A
- CDZI N/A
- Revenue
- AVIR N/A
- CDZI $11,441,000.00
- Revenue This Year
- AVIR N/A
- CDZI $75.05
- Revenue Next Year
- AVIR N/A
- CDZI $12.18
- P/E Ratio
- AVIR N/A
- CDZI N/A
- Revenue Growth
- AVIR N/A
- CDZI 283.67
- 52 Week Low
- AVIR $2.46
- CDZI $2.13
- 52 Week High
- AVIR $4.15
- CDZI $5.68
- Technical
- Relative Strength Index (RSI)
- AVIR 56.05
- CDZI 52.32
- Support Level
- AVIR $2.78
- CDZI $2.76
- Resistance Level
- AVIR $3.03
- CDZI $3.06
- Average True Range (ATR)
- AVIR 0.17
- CDZI 0.17
- MACD
- AVIR 0.03
- CDZI 0.01
- Stochastic Oscillator
- AVIR 88.03
- CDZI 45.62
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About CDZI CADIZ Inc.
Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, which derives key revenue, and comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, which provides water filtration solutions for impaired or contaminated groundwater sources.